Related Experiment Video

Updated: Mar 29, 2026

Stimulation of Notch Signaling in Mouse Osteoclast Precursors
08:01

Stimulation of Notch Signaling in Mouse Osteoclast Precursors

Published on: February 28, 2017

8.4K

Wogonin inhibits osteoclast differentiation by inhibiting NFATc1 translocation into the nucleus

Xiaolin Geng1, Libin Yang1, Chao Zhang1

  • 1Department of Orthopedic Surgery I, The First Affiliated Hospital of Xinxiang Medical University, Weihui, Henan 453100, P.R. China.

Experimental and Therapeutic Medicine
|December 2, 2015
PubMed

Insights

Wogonin, a natural product, inhibits nuclear factor of activated T cells c1 (NFATc1) translocation and osteoclast differentiation. This discovery offers potential new treatments for osteoporosis.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Pharmacology

Background:

  • Osteoclast differentiation is crucial for bone remodeling and is implicated in bone diseases like osteoporosis.
  • Nuclear factor of activated T cells c1 (NFATc1) plays a key role in osteoclast differentiation.
  • Identifying natural products that modulate NFATc1 activity could lead to novel therapeutic strategies.

Purpose of the Study:

  • To screen for natural products inhibiting NFATc1 translocation.
  • To investigate the effects of identified compounds on osteoclast differentiation.
  • To elucidate the molecular mechanisms underlying the observed effects.

Main Methods:

  • High-throughput screening using an NFATc1 antagonist redistribution assay in U2OS-NFATc1 cells.
  • Luciferase assay to assess NFATc1 transcriptional activity.
  • Osteoclast differentiation assay and quantitative PCR to analyze gene expression.

Main Results:

  • Wogonin was identified as a natural product that inhibits NFATc1 translocation and transcriptional activity.
  • Wogonin significantly suppressed osteoclast differentiation.
  • Wogonin decreased the expression of key osteoclast-related genes, including OSCAR, TRAP, and CALCR.

Conclusions:

  • Wogonin inhibits osteoclast differentiation by blocking NFATc1 nuclear translocation and subsequent gene transcription.
  • Wogonin demonstrates potential as a therapeutic agent for osteoporosis by targeting osteoclastogenesis.
  • Further research into Wogonin's mechanism and efficacy is warranted for osteoporosis treatment.
Keywords:
NFATc1Wogoninosteoclastosteoporosis

More Related Videos

A Simple Pit Assay Protocol to Visualize and Quantify Osteoclastic Resorption In Vitro07:03

A Simple Pit Assay Protocol to Visualize and Quantify Osteoclastic Resorption In Vitro

Published on: June 16, 2022

7.7K
Effect of Anti-c-fms Antibody on Osteoclast Formation and Proliferation of Osteoclast Precursor In Vitro07:51

Effect of Anti-c-fms Antibody on Osteoclast Formation and Proliferation of Osteoclast Precursor In Vitro

Published on: March 18, 2019

6.4K

Related Concept Videos

Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
10.9K
Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

2.6K
Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
4.7K
Co-activators and Co-repressors02:04

Co-activators and Co-repressors

Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
8.9K
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
10.3K
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
8.6K